Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Yogen Saunthararajah, MD
Researcher Professor of Medicine
Cleveland Clinic Main Campus
9500 Euclid Avenue
Cleveland, Ohio, United States
Yogen Saunthararajah, MD, is a staff in the department of Hematologic Oncology and Blood Disorders at Cleveland Clinic, a professor of medicine, and co-leader of the developmental therapeutics program of the Case Comprehensive Cancer Center.
His clinical and research interests include acute myeloid leukemia, myelodysplastic syndrome, sickle cell disease/anemia, thalassemia, leukemia, benign hematology, myelodysplasia, cancer, leukopenia, aplastic anemia.
Dr. Yogen developed an Epigenetic Platform that has the potential to identify and eliminate the “road blocks” that prevent cancer cells from becoming specialized, non-dividing cells. According to him, the methodology can be applied to some of the most common and most debilitating genetic disorders in the world, including sickle cell disease and beta thalassemia.
+myBinderRelated Content
-
Eric E. Bouhassira, PhDDr. Eric E. Bouhassira joined the Albert...
-
Hospitals See No Link Between US Opioid Crisis and Patients’ Use of Treatment, Study ReportsThe U.S. opioid epidemic is not linked t...
-
Sickle Cell Disease Care TeamSickle cell disease (SCD) is an inherit...
-
David Beidler, PhDAs the Translational Sciences lead for t...
-
Sickle Cell Emergency Room Care: From Patients to Providershttps://www.youtube.com/watch?time_conti...
-
Patient-reported experience measure in sickle cell diseaseObjectives: To develop patient-reported...
-
NewYork-Presbyterian Brooklyn Methodist HospitalThe Sickle Cell/Thalassemia Program at N...
